AstraZeneca, the U.K.-Swedish pharmaceutical giant, on Tuesday announced a plan to invest some $50 billion in the U.S. in a move hailed by the Trump administration — though much of what it is announcing it’s already announced before.
Source link
AstraZeneca to build new Virginia plant as it re-hashes other U.S. investment plans
By Daniel snow
